Isolation rearing impaired sensorimotor gating but increased pro-inflammatory cytokines and disrupted metabolic parameters in both sexes of rats

Psychoneuroendocrinology

Volumn 55, Issue , 2015, Pages 173-183

  Ko, Chih Yuan ^a   Liu, Yia Ping ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Cytokines; Development; Metabolic abnormalities; Schizophrenia; Sex; Social isolation rearing

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; IL1B PROTEIN, RAT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOCOMOTION; MALE; MATSUDA INDEX; METABOLIC DISORDER; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PUBERTY; RAT; REARING; SENSORY GATING; SEX DIFFERENCE; SOCIAL ISOLATION; WEIGHT GAIN; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODEL; IMMUNOLOGY; LIPID METABOLISM; MATERNAL DEPRIVATION; METABOLISM; MOTOR ACTIVITY; PSYCHOLOGY; SCHIZOPHRENIA;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; C-REACTIVE PROTEIN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INSULIN RESISTANCE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPID METABOLISM; MALE; MATERNAL DEPRIVATION; MOTOR ACTIVITY; PREPULSE INHIBITION; RATS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSORY GATING; SEX FACTORS; SOCIAL ISOLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925796551     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2015.02.007     Document Type: Article

References (58)

1. Afsar B. Disruption of circadian blood pressure, heart rate and the impact on glycemic control in type 1 diabetes. Diabet. Metab. Syndr. 2014, pii:S1871-4021(14)00051-4 [Epub ahead of print]. 10.1016/j.dsx.2014.05.002.
2. Amsen D., de Visser K.E., Town T. Approaches to determine expression of inflammatory cytokines. Methods Mol. Biol. 2009, 511:107-142.
3. Ansell B.J. Evidence for a combined approach to the management of hypertension and dyslipidemia. Am. J. Hypertens. 2005, 18:1249-1257.
4. Bakshi V.P., Geyer M.A. Ontogeny of isolation rearing-induced deficits in sensorimotor gating in rats. Physiol. Behav. 1999, 67:385-392.
5. Bautista L.E., Vera L.M., Arenas I.A., Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J. Hum. Hypertens. 2005, 19:149-154.
6. Beumer W., Drexhage R.C., De Wit H., Versnel M.A., Drexhage H.A., Cohen D. Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology 2012, 37:1901-1911.
7. Breder C.D., Tsujimoto M., Terano Y., Scott D.W., Saper C.B. Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. J. Comp. Neurol. 1993, 337:543-567.
8. Conti C.M., Fulcheri M. Interlationship between psychology and cytokines. J. Biol. Regul. Homeost. Agents 2010, 24:485-490.
9. Chang H.A., Liu Y.P., Tung C.S., Chang C.C., Tzeng N.S., Huang S.Y. Effects of REM sleep deprivation on sensorimotor gating and startle habituation in rats: role of social isolation in early development. Neurosci. Lett. 2014, 575:63-67.
10. Dasgupta A., Singh O.P., Rout J.K., Saha T., Mandal S. Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:1202-1207.
11. De Hert M.A., van Winkel R., Van Eyck D., Hanssens L., Wampers M., Scheen A., et al. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr. Res. 2006, 83:87-93.
12. del Rey A., Besedovsky H. Interleukin 1 affects glucose homeostasis. Am. J. Physiol. 1987, 253:794-798.
13. Erta M., Quintana A., Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int. J. Biol. Sci. 2012, 8:1254-1266.
14. Fone K.C.F., Porkess M.V. Behavioural and neurochemical effects of post-weaning social isolation in rodents - relevance to developmental neuropsychiatric disorders. Neurosci. Biobehav. Rev. 2008, 32:1087-1102.
15. Faraday M.M. Rat sex and strain differences in responses to stress. Physiol. Behav. 2002, 75:507-522.
16. Geyer M.A., Wilkinson L.S., Humby T., Robbins T.W. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol. Psychiatry 1993, 34:361-372.
17. Gladkevich A., Kauffman H.F., Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:559-576.
18. Hellemans K.G.C., Benge L.C., Olmstead M.C. Adolescent enrichment partially reverses the social isolation syndrome. Dev. Brain Res. 2004, 150:103-115.
19. Holson R.R., Scallet A.C., Ali S.F., Turner B.B. Isolation stress revisited: isolation-rearing effects depend on animal care methods. Physiol. Behav. 1991, 49:1107-1118.
20. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
21. Hsieh P.S., Lu K.C., Chiang C.F., Chen C.H. Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats. Eur. J. Clin. Invest. 2010, 40:164-171.
22. Ibi D., Takuma K., Koike H., Mizoguchi H., Tsuritani K., Kuwahara Y., et al. Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice. J. Neurochem. 2008, 105:921-932.
23. Javanbakht A. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia. Med. Hypotheses 2006, 67:1173-1184.
24. Jones C.A., Watson D.J.G., Fone K.C.F. Animal models of schizophrenia. Br. J. Pharmacol. 2011, 164:1162-1194.
25. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E745-E751.
26. Knight J.G., Knight A., Pert C.B. Is schizophrenia a virally triggered antireceptor autoimmune disease?. Biological Perspectives of Schizophrenia 1987, 107-127. Wiley, New York, NY. H. Helmchen, F.A. Henn (Eds.).
27. Lee S.Y., Park M.H., Patkar A.A., Pae C.U. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic in patients treated with aripiprazole, olanzapine, quetiapine or risperidone. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:490-496.
28. Liu Y.P., Kao Y.C., Tung C.S. Critical period exists in the effects of isolation rearing on sensorimotor gating function but not locomotor activity in rat. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1068-1073.
29. Lukasz B., O'Sullivan N.C., Loscher J.S., Pickering M., Regan C.M., Murphy K.J. Peripubertal viral-like challenge and social isolation mediate overlapping but distinct effects on behaviour and brain interferon regulatory factor 7 expression in the adult Wistar rat. Brain Behav. Immun. 2013, 27:71-79.
30. Maedler K., Sergeev P., Ris F., Oberholzer J., Joller-Jemelka H.I., Spinas G.A., et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 2002, 110:851-860.
31. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
32. McGrath J., Saha S., Chant D., Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol. Rev. 2008, 30:67-76.
33. Meyer U. Developmental neuroinflammation and schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2013, 42:20-34.
34. Mikkola I., Keinänen-Kiukaanniemi S., Laakso M., Jokelainen J., Härkönen P., Meyer-Rochow V.B., et al. Metabolic syndrome in connection with BMI in young Finnish male adults. Diabetes Res. Clin. Pract. 2007, 76:404-409.
35. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70:663-671.
36. Miranda P.J., DeFronzo R.A., Califf R.M., Guyton J.R. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 2005, 149:33-45.
37. Mitchell A.J., Vancampfort D., De Herdt A., Yu W., De Hert M. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr. Bull. 2013, 39:295-305.
38. Möller M., Du Preez J.L., Viljoen F.P., Berk M., Emsley R., Harvey B.H. Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine. Brain Behav. Immun. 2013, 30:156-167.
39. Müller N., Dobmeier P., Empl M., Riedel M., Schwarz M., Ackenheil M. Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients. Eur. Psychiatry 1997, 12:294-299.
40. Okumura Y., Ito H., Kobayashi M., Mayahara K., Matsumoto Y., Hirakawa J. Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: a nationwide retrospective cohort study. Schizophr. Res. 2010, 119:145-152.
41. O'Rourke R.W., White A.E., Metcalf M.D., Winters B.R., Diggs B.S., Zhu X., et al. Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice. Metabolism. 2012, 61:1152-1161.
42. Osburg B., Peiser C., Domling D., Schomburg L., Ko Y.T., Voigt K., et al. Effect of endotoxin on expression of TNF receptors and transport of TNF-alpha at the blood-brain barrier of the rat. Am. J. Physiol. Endocrinol. Metab. 2002, 283:899-908.
43. Ozaki K., Leonard W.J. Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem. 2002, 277:29355-29358.
44. Park H.S., Park J.Y., Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract. 2005, 69:29-35.
45. Powell S.B., Swerdlow N.R., Pitcher L.K., Geyer M.A. Isolation rearing-induced deficits in prepulse inhibition and locomotor habituation are not potentiated by water deprivation. Physiol. Behav. 2002, 77:55-64.
46. Prasad K., Dhar I. Oxidative stress as a mechanism of added sugar-induced cardiovascular disease. Int. J. Angiol. 2014, 23:217-226.
47. Quagliarello V.J., Wispelwey B., Long W.J., Scheld W.M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J. Clin. Invest. 1991, 87:1360-1366.
48. Richard M.D., Brahm N.C. Schizophrenia and the immune system: pathophysiology, prevention, and treatment. Am. J. Health. Syst. Pharm. 2012, 69:757-766.
49. Ryan M.C., Collins P., Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am. J. Psychiatry 2003, 160:284-289.
50. Spelman L.M., Walsh P.I., Sharifi N., Collins P., Thakore J.H. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia. Diabet. Med. 2007, 24:481-485.
51. Suvisaari J., Loo B.M., Saarni S.E., Haukka J., Perälä J., Saarni S.I., et al. Inflammation in psychotic disorders: a population-based study. Psychiatry Res. 2011, 189:305-311.
52. Tohmi M., Tsuda N., Watanabe Y., Kakita A., Nawa H. Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin. Neurosci. Res. 2004, 50:67-75.
53. Tomasik J., Rahmoune H., Guest P.C., Bahn S. Neuroimmune biomarkers in schizophrenia. Schizophr. Res. 2014, pii:S0920-9964(14)00382-X [Epub ahead of print]. 10.1016/j.schres.2014.07.025.
54. Upthegrove R., Manzanares-Teson N., Barnes N.M. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr. Res. 2014, 155:101-108.
55. Vereker E., O'Donnell E., Lynch A., Kelly A., Nolan Y., Lynch M.A. Evidence that interleukin-1beta and reactive oxygen species production play a pivotal role in stress-induced impairment of LTP in the rat dentate gyrus. Eur. J. Neurosci. 2001, 14:1809-1819.
56. Weiss I.C., Domeney A.M., Heidbreder C.A., Moreau J.L., Feldon J. Early social isolation, but not maternal separation, affects behavioral sensitization to amphetamine in male and female adult rats. Pharmacol. Biochem. Behav. 2001, 70:397-409.
57. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115:1111-1119.
58. Yu H., Zheng L., Xu L., Yin L., Lin Y., Li H., et al. Potent effects of the total saponins from dioscorea nipponica makino against streptozotocin-induced type 2 diabetes mellitus in rats. Phytother. Res. 2014, 10.1002/ptr.5243 [Epub ahead of print].